Skip to content

WilMed

Active Private limited companyfounded 2024active for 2 yearsSonatinestraat 86, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 1011.375.448

Lifetime

2 annual accounts with figures on one time axis
peak of €197,911 in 2025
€197,911▲ 29.8%
peak of €151,210 in 2025
€151,210▲ 37.9%
peak of €112,678 in 2024
€110,888▼ 1.6%
€203,060▲ 374%
Board1 name since 2024
1 director
Documentsfilings and deeds
17-07-202614 days before the deadline
2025micro format
Gross margin from €152,504 to €197,911Result from €109,678 to €151,210Dividend €153,000Debts from €42,835 to €203,060Cash from €26,243 to €161,298

Key points

from the 2025 annual accounts

Equity

€110,888 ▼ 1.6%
112,6782024+151,210Profit-153,000Dividend110,8882025

WilMed paid out €153,000 in dividends. That is 101% of the 2025 profit.

Turnover

≈ €360,000 estimated

The micro format states no turnover.

Liquidity

1.45 was 3.05 in 2024

Short-term debts rose from €42,835 to €203,060.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as WilMed has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for WilMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 09-07-2024
  • 100 sharesdeed of 11-07-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1011375448
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 11-07-2024 · Gazette deed
All 5 events

Comparable companies

same main activity, similar in size and age
Company
WilMed Molenbeek-Saint-Jean €313,948 €197,911 35.3% -
Docteur HOUILLON GAETAN Tellin €290,119 €186,351 42.8% -
Médecine Générale JPX Merbes-le-Château €329,943 €186,597 80.6% -
JDMEDIC Marche-en-Famenne €277,732 €190,203 96.5% -
DOKBC Sint-Gillis (bij-Brussel) €355,354 €169,573 72.8% -
Docteur Adriana CONSTANTIN Anderlecht €424,435 €188,143 65.6% -
Dr. Jo Peeters Houthalen-Helchteren €330,725 €209,547 62.1% 0.5

These companies have the same main activity as WilMed: general medical practice (NACE 86210). They are comparable in size and age: total assets between €278,000 and €424,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 09-07-2024Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.362.877.4381080 Molenbeek-Saint-Jean, since 09-07-2024
Financial year end
31 December
Peppol
Reachable since 23-10-2025
Company details

Annual accounts 2025

€313,948▲ 102%
Filing
Filed on 17-07-2026, 14 days before the end of the filing period
Financials

Insights on WilMed

WilMed has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,888 and a net result of €151,210.

Its solvency ranks better than 29% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about WilMed

What is the company number of WilMed?
The company number of WilMed is 1011.375.448. The VAT number is the same number with BE in front: BE 1011.375.448.
Where is WilMed based?
The registered office is at Sonatinestraat 86, 1080 Molenbeek-Saint-Jean.Company details
What does WilMed do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of WilMed?
WilMed is a private limited company (BV).
When was WilMed founded?
WilMed was founded on 09-07-2024.
Is WilMed still active?
Yes, WilMed is an active enterprise in the KBO register.
What is the turnover of WilMed?
The turnover in financial year 2025 is about €360,000. This figure is estimated from the gross margin of €197,911 and 30 comparable companies (NACE 86210). It probably lies between €290,000 and €450,000.Financials
Is WilMed profitable?
In financial year 2025, WilMed made a profit of €151,210.
Where can I find the annual accounts of WilMed?
WilMed filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of WilMed due?
WilMed must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.